Manning & Napier Advisors’s GSK GSK Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $7.04M | Sell |
183,292
-16,708
| -8% | -$642K | 0.08% | 146 |
|
2025
Q1 | $7.75M | Hold |
200,000
| – | – | 0.1% | 135 |
|
2024
Q4 | $6.76M | Buy |
200,000
+50,000
| +33% | +$1.69M | 0.08% | 141 |
|
2024
Q3 | $6.13M | Hold |
150,000
| – | – | 0.07% | 167 |
|
2024
Q2 | $5.78M | Buy |
+150,000
| New | +$5.78M | 0.07% | 161 |
|
2015
Q2 | – | Sell |
-279,684
| Closed | -$16.1M | – | 371 |
|
2015
Q1 | $16.1M | Sell |
279,684
-5,579
| -2% | -$322K | 0.08% | 128 |
|
2014
Q4 | $15.2M | Buy |
285,263
+18,495
| +7% | +$988K | 0.07% | 136 |
|
2014
Q3 | $15.3M | Buy |
266,768
+1,533
| +0.6% | +$88.1K | 0.06% | 139 |
|
2014
Q2 | $17.7M | Buy |
265,235
+1,993
| +0.8% | +$133K | 0.07% | 128 |
|
2014
Q1 | $17.6M | Sell |
263,242
-43,716
| -14% | -$2.92M | 0.07% | 124 |
|
2013
Q4 | $20.5M | Sell |
306,958
-13,171
| -4% | -$879K | 0.09% | 108 |
|
2013
Q3 | $20.1M | Buy |
320,129
+3,950
| +1% | +$248K | 0.09% | 103 |
|
2013
Q2 | $19.7M | Buy |
+316,179
| New | +$19.7M | 0.11% | 95 |
|